A comprehensive review of topical hemostatic agents: The good, the bad, and the novel.
Journal
The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
19
10
2019
medline:
25
6
2020
entrez:
19
10
2019
Statut:
ppublish
Résumé
Uncontrolled exsanguination remains the leading cause of death for trauma patients, many of whom die in the pre-hospital setting. Without expedient intervention, trauma-associated hemorrhage induces a host of systemic responses and acute coagulopathy of trauma. For this reason, health care providers and prehospital personal face the challenge of swift and effective hemorrhage control. The utilization of adjuncts to facilitate hemostasis was first recorded in 1886. Commercially available products haves since expanded to include topical hemostats, surgical sealants, and adhesives. The ideal product balances efficacy, with safety practicality and cost-effectiveness. This review of hemostasis provides a guide for successful implementation and simultaneously highlights future opportunities.
Identifiants
pubmed: 31626024
doi: 10.1097/TA.0000000000002508
pii: 01586154-202001000-00027
doi:
Substances chimiques
Hemostatics
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e21Références
Gruen RL, Brohi K, Schreiber M, Balogh ZJ, Pitt V, Narayan M, Maier RV. Haemorrhage control in severely injured patients. Lancet. 2012;380:1099–1108.
Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(Suppl 6):S3–S11.
Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.
Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anaesthesia. 2015;70(1):96–101.
Cap A, Hunt BJ. Acute Traumatic Coagulopathy. Curr Opin Crit Care. 2014; 20(6):638–645.
Stop the Bleed. American College of Surgeons, 2008, http://www.bleedingcontrol.org. Accessed 16 Apr. 2018.
Sileshi B, Achneck HE, Lawson JH. Management of surgical hemostasis: topical agents. Vascular. 2008;(16 Suppl 1):S22–S28.
Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg. 2008;34(4):431–445.
Spotnitz WD. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg. 2012;78(12):1305–1321.
Gabay M, Boucher BA. An Essential Primer for Understanding the Role of Topical Hemostats, Surgical Sealants and Adhesives for Maintaining Hemostasis. Pharmacotherapy. 2013;33(9):935–955.
Emilia M, Luca S, Francesca B, Luca B, Paolo S, Giuseppe F, Gianbattista B, Carmela M, Luigi M, Mauro L. Topical hemostatic agents in surgical practice. Transfus Apher Sci. 2011;45(3):305–311.
Neveleff D. Optimizing hemostatic practices: matching the appropriate hemostat to the clinical situation. AORN J. 2012;96(5):S1–S17.
Spotnitz WD, Burks S. State-of-the-art review: hemostats, sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost. 2010;16(5):497–514.
Howe N, Cherpelis B. Obtaining rapid and effective hemostasis: Part I. Update and review of topical hemostatic agents. J Am Acad Dermatol. 2013;69(5):659.e1–659.e17.
Gabay M. Absorbable hemostatic agents. Am J Health Syst Pharm. 2006;63(13):1244–1253.
Simo KA, Hanna EM, Imagawa DK, Iannitti DA. Hemostatic agents in hepatobiliary and pancreas surgery: a review of the literature and critical evaluation of a novel carrier-bound fibrin sealant (TachoSil). ISRN Surg. 2012;2012:729086.
Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;(13 Suppl 1):S89–S96.
Ferraris VA, Brown JR, Despotis GJ, et al. 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91(3):944–982.
Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg. 2008;95(10):1197–1225.
Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg. 2010;251(2):217–228.
Saif R, Jacob M, Robinson S, Amer A, Kei-Hui D, Sen G, Manas D, White S. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery. Surg Laparosc Endosc Percutan Tech. 2011;21(3):131–141.
Wound Clot Products. Core Scientific Creations, http://www.woundclot.com./ Accessed 16 Apr. 2018.
BloodSTOP. LifeSciences PLUS, 2018, http://www.lifesciencesplus.com/. Accessed 16 Apr. 2018.
Barnard J, Millner R. A review of topical hemostatic agents for use in cardiac surgery. Ann Thorac Surg. 2009;88(4):1377–1383.
Perclot PHS Polysaccharide Hemostatic System [package insert]. San Jose, CA: Starch Medical Inc.; 2017.
Thrombin-JMI (Thrombin Topical (Bovine) U.S.P.) [package insert]. Middleton, WI: GenTrac Inc.; 2017.
Evithrom (topical human thrombin) [package insert]. Sommerville, NJ: Johnson & Johnson; 2007.
Recothrom Thrombin topical (Recombinant) [package insert]. Hazelwood, MO: Mallinckrodt Hospital Products, Inc.; 2016.
Oz MC, Cosgrove DM 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, Topic N. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000;69(5):1376–1382.
Oz MC, Rondinone JF, Shargill NS. Floseal matrix: new generation topical hemostatic sealant. J Card Surg. 2003;18:486–493.
FloSeal Hemostatic Matrix [package insert]. Fremont, CA: Baxter Healthcare Corporation; 2005.
Richter F, Schnorr D, Deger S, Trk I, Roigas J, Wille A, Loening SA. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (Floseal). Urology. 2003;61(1):73–77.
Groenewold MD, Gribnau AJ, Ubbink DT. Topical haemostatic agents for skin wounds: a systematic review. BMC Surg. 2011;11:15.
Schexneider KI. Fibrin Sealants in surgical or traumatic hemorrhage. Curr Opin Hematol. 2004;11(5):323–326.
Mandell SP, Gibran NS. Fibrin Sealants: surgical hemostat, sealant and adhesive. Expert Opin Biol Ther. 2014;14(6):821–830.
Bochicchio G, Dunne J, Bochicchio K, Scalea T. The combination of platelet-enriched autologous plasma with bovine collagen and thrombin decreases the need for multiple blood transfusions in trauma patients with retroperitoneal bleeding. J Trauma. 2004;56(1):76–79.
EVARREST Fibrin Sealant Patch [package insert]. Nes-Ziona, Israel: Omrix Biopharmaceuticals Ltd.; 2016.
Fischer CP, Bochicchio G, Shen J, Patel B, Batiller J, Hart JC. A prospective, randomized, controlled trial of efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic and thoracic surgery. J Am Coll Surg. 2013;217(3):385–393.
Koea JB, Batiller J, Patel B, Shen J, Hammond J, Hart J, Fischer C, Garden OJ. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB (Oxford). 2013;15(1):61–70.
Ozawa S. Patient blood management: use of topical hemostatic and sealant agents. AORN J. 2013;98:461–478.
Glickman M, Gheissari A, Money S, Martin J, Ballard JL; Coseal Multicenter Vascular Surgery Study Group. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial. Arch Surg. 2002;137(3):326–331; discussion 332.
DeAnda A, Elefteriades JA, Hasaniya NW, Lattouf OM, Lazzara RR. Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery. J Card Surg. 2009;24(3):325–333.
Kim KD, Wright NM. Polyethylene glycol hydrogel spinal sealant (DuraSeal Spinal Sealant) as an adjunct to sutured dural repair in the spine: results of prospective, multi center, randomized controlled trial. Spine. 2011;36(23):1906–1912.
Fuller C. Reduction of intraoperative air leaks with Progel in pulmonary resection: a comprehensive review. J Cardiothorac Surg. 2013;8:90.
Klingler CH, Remzi M, Marberger M, Janetschek G. Haemostasis in laparoscopy. Eur Urol. 2006;50(5):948–956; discussion 956-7.
Yanazume S, Douzono H, Yanazume Y, Iio K, Douchi T. New hemostatic method using Mohs' paste for fatal genital bleeding in advanced cervical cancer. Gynecol Oncol Case Rep. 2013;4:47–49.
Kakimoto M, Tokita H, Okamura T, Yoshino K. A chemical hemostatic technique for bleeding from malignant wounds. J Palliat Med. 2010;13(1):11–13.
Hwa C, Kovich OI, Stein JA. Achieving hemostasis after nail biopsy using absorbable gelatin sponge saturated in aluminum chloride. Dermatol Surg. 2011;37(3):368–369.
Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(4):865–875.
Low TH, Huang J, Reid C, Elliot M, Clark JR. Treatment of bleeding upper aero digestive tract tumor—a novel approach with antifibrinolytic agent: case series and literature review. Laryngoscope. 2013;123(10):2449–2452.
Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.
Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev. 2013;(7):CD010562.
Coetzee MJ. The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia. Haemophilia. 2007;13(4):443–444.
Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee. 2013;20(5):300–309.
Schreiber MA, Tieu B. Hemostasis in Operation Iraqi Freedom III. Surgery. 2007;142(Suppl 4):S61–S66.
Chito-seal [package insert]. Charlottesville, VA: Luna Innovations; 2013.
Clor-Sur P.A.D.[package insert]. Miami, FL: Scion Biomedical; 2004.
Gel-e Bandange [package insert]. College Park, MD: Gel-e Inc; 2017.
Kheirabadi BS, Acheson EM, Deguzman R, Sondeen JL, Ryan KL, Delgado A, Dick EJ Jr., Holcomb JB. Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine. J Trauma. 2005;59(1):25–34.
Sondeen JL, Pusateri AE, Coppes VG, Gaddy CE, Holcomb JB. Comparison of 10 different hemostatic dressings in an aortic injury. J Trauma. 2003;54(2):280–285.
Greary JR, Frantz VK. New Absorbable Hemostatic Bone Wax. Ann Surg. 1950;132:1128–1137.
Magyar CE, Aghaloo TL, Atti E, Tetradis S. Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing. Neurosurgery. 2008;63(4 Suppl 2):373–378; discussion 378.
Glick JB, Kaur RR, Siegel D. Achieving hemostasis in dermatology-Part II: Topical hemostatic agents. Indian Dermatol Online J. 2013;4(3):172–176.
Gelfoam (absorbable gelatin sponge, USP) [package insert]. Hayward, CA: Baxter Healthcare Corporation; 2011.
Surgifoam (absorbable gelatin sponge, USP) [package insert]. Sommerville, NJ: Johnson & Johnson; 2002.
Arista AH. Absorbable Hemostatic Particles [package insert]. Warwick, RI: Davol Inc.; 2015.
“Vitagel Features & Benefits.” Stryker, http://www.stryker.com/en-us/products/Orthobiologicals/SoftTissue/Vitagel/index.htm. Accessed on 16 Apr. 2018.
Morse DC, Silva E, Bartrom J, Young K, Base EJ, Potter D, Bieber T. Improved bleeding scores using Gelfoam Powder with incremental concentrations of bovine thrombin in a swine liver lesion model. J Thromb Thrombolysis. 2016;42(3):352–359.
Samudrala S. Topical hemostatic agents in surgery: a surgeon's perspective. AORN J. 2008;88(3):S2–S11.
Frantz VK. Absorbable Cotton, Paper and Gauze: (oxidized cellulose). Ann Surg. 1943;118:116–126.
Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect (Larchmt). 2003;4(3):255–262.
“Vitasure Features & Benefits.” Stryker Soft Tissue, www.stryker.com/en-us/products/Orthobiologicals/SoftTissue/Vitasure?index.htm. Accessed 6 Apr. 2018.
Barkun AN, Moosavi S, Martel M. Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleeding. Gastrointest Endosc. 2013;77(5):692–700.
Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958–965.
Evans LA, Morey AF. Hemostatic agents and tissue glues in urologic injuries and wound healing. Urol Clin North Am. 2006;33(1):1–12.
Tisseel (Fibrin Sealant) [package insert]. Deerfield IL: Baxter Healthcare Corporation; 1998.
Evicel [package insert]. Sommerville, NJ: Johnson & Johnson; 2006.
“EVARREST Fibrin Sealant Patch.” Sommerville, NJ; Ethicon, https://www.ethicon.com/na/products/adjunctive-hemostasis/absorbable-hemostats/evarrest-fibrin-sealant-patch.com/. Accessed on 16 Apr. 2018.
Bioglue Surgical Adhesive [package insert]. Kennesaw, GA: Cryolife Inc.; 2014.
Omnex Surgical Sealant [package insert]. Sommerville, NJ: Ethicon; 2010.
Bhende S, Rothenburger S, Spangler DJ, Dito M. In Vitro assessment of microbial barrier properties of Dermabond topic skin adhesive. Surg Infect (Larchmt). 2002;3(3):251–257.
Mertz PM, Davis SC, Cazzaniga AL, Drosou A, Eaglstein WH. Barrier and antibacterial properties of 2-octyl cyanoacrylate-derived wound treatment films. J Cutan Med Surg. 2003;7(1):1–6.
Naftalin LW, Yagiela JA. Vasoconstrictors: indication and precautions. Dent Clin N Am. 2002;46(4):733–746.
Narang U, Mainwaring L, Spath G, Barefoot J. In -vitro analysis for microbial barrier properties of 2-octyl cyanoacrylate-derived wound treatment films. J Cutan Med Surg. 2003;7(1):13–19.
http://www.gel-e.co. Accessed 16 April 2018.
Dowling MB, Chaturvedi A, MacIntire IC, Javvaji V, Gustin J, Raghavan SR, Scalea TM, Narayan M. Determination of efficacy of a novel alginate dressing in a lethal arterial injury model in swine. Injury. 2016;47(10):2105–2109.
Dowling MB, MacIntire IC, White JC, Narayan M, Duggan MJ, King DR, Raghavan SR. Sprayable foams based on an amphiphilic biopolymer for control of hemorrhage without compression. ACS Biomater Sci Eng. 2015;1:440–447.